Paper42412349
Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.
Wakatsuki R and 16 others. Int J Hematol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome. Papers, record 42412349. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42412349
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Transplantation Conditioning | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Hyper-IgM Immunodeficiency Syndrome, Type 1 | Major topic |
| Humans | |
| Child, Preschool | |
| Male | |
| Female | |
| Transplantation, Homologous | |
| Vidarabine | |
| Graft vs Host Disease | |
| Busulfan | |
| Whole-Body Irradiation | |
| Survival Rate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22K07887 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23797640 | The hyper IgM syndromes. | Clin Rev Allergy Immunol | 2014 | https://conductscience.org/library/papers/23797640 | PubMed |
| 2 | 27697500 | Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/27697500 | PubMed |
| 3 | 38568018 | Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure. | Hematology | 2024 | https://conductscience.org/library/papers/38568018 | PubMed |
| 4 | 29132233 | Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome. | Innate Immun | 2018 | https://conductscience.org/library/papers/29132233 | PubMed |
| 5 | 7681587 | Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7681587 | PubMed |
| 6 | 7679801 | CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. | Science | 1993 | https://conductscience.org/library/papers/7679801 | PubMed |
| 7 | 32849512 | Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849512 | PubMed |
| 8 | 16630945 | Defects of class-switch recombination. | J Allergy Clin Immunol | 2006 | https://conductscience.org/library/papers/16630945 | PubMed |
| 9 | 33527309 | Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases. | J Clin Immunol | 2021 | https://conductscience.org/library/papers/33527309 | PubMed |
| 10 | 8094231 | CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. | Nature | 1993 | https://conductscience.org/library/papers/8094231 | PubMed |
| 11 | 41608114 | Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. | J Hum Immun | 2025 | https://conductscience.org/library/papers/41608114 | PubMed |
| 12 | 36797422 | Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders. | Bone Marrow Transplant | 2023 | https://conductscience.org/library/papers/36797422 | PubMed |
| 13 | 7679206 | Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. | Nature | 1993 | https://conductscience.org/library/papers/7679206 | PubMed |
| 14 | 7678782 | The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. | Cell | 1993 | https://conductscience.org/library/papers/7678782 | PubMed |
| 15 | 14663287 | The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. | Medicine (Baltimore) | 2003 | https://conductscience.org/library/papers/14663287 | PubMed |
| 16 | 22038983 | Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan. | Pediatr Blood Cancer | 2012 | https://conductscience.org/library/papers/22038983 | PubMed |
| 17 | 34226669 | EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/34226669 | PubMed |
| 18 | 35759077 | B-Cell Immune Reconstitution with Mixed Chimerism After Hematopoietic Cell Transplantation in a Patient with Severe Combined Immunodeficiency. | J Clin Immunol | 2022 | https://conductscience.org/library/papers/35759077 | PubMed |
| 19 | 42002229 | Posttransplant Chimerism Estimation Using Variant-Specific ddPCR in Inborn Errors of Immunity. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/42002229 | PubMed |
| 20 | 30660643 | Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study. | J Allergy Clin Immunol | 2019 | https://conductscience.org/library/papers/30660643 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD40LG | 959 | PubTator's text mining | https://conductscience.org/library/genes/959 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42412349
GET https://conductscience.org/api/papers/v1/42412349/references?page=2